eyeforpharma
Contact us  |  Cookie policy
  Pharmaceutical Growth Markets 2013-2014  

Contents

Check out the contents to learn a little more about what you'll receive in our Multichannel Marketing report.

Click here to receive even more information from our Report Extract

  • 5.1 Opportunities 40
    • 5.1.1 Generics Act coming to fruition 40
    • 5.1.2 Rising disease prevalence 40
    • 5.1.3 Partnering for success 40
    • 5.1.4 Private market growth 41
  • 5.2 Challenges 41
    • 5.2.1 Regulations 41
    • 5.2.2 Poor infrastructures hinder pharma operations 42
    • 5.2.3 Illegal pharma production 42
  • 5.3 Access issues 43
  • 5.4 Reimbursement 43
  • 5.4.1 Squeeze of prices 43
  • 6.0 Mexico 45
    • 6.0.1 Universal healthcare coverage a goal, private-sector spending on rise 46
    • 6.0.2 Branded products gaining ground 47
  • 6.1 Opportunities 47
    • 6.1.1 Specializing in niche areas the main focus 47
  • 6.2 Challenges48
    • 6.2.1 Mexican companies take a bullish stance 48
    • 6.2.2 Government out to drive down costs 48
  • 6.3 Access issues 49
  • 6.4 Reimbursement 49
  • 7.0 Venezuela 50
  • 7.1 Opportunities 50
    • 7.1.1 Careful targeting crucial 51
  • 7.2 Challenges 51
    • 7.2.1 Currency controls the main challenge 51
    • 7.2.2 Price controls an additional burden 52
  • 7.3 Access issues 52
  • 7.4 Reimbursement 53
  • 8.0 Indonesia 55
  • 8.1 Opportunities 55
    • 8.1.1 Roll-out of universal healthcare 55
    • 8.1.2 Clear win-win for pharma-insurer partnerships 55
  • 8.2 Challenges56
    • 8.2.1 Weak infrastructure 56
  • 8.3 Access issues 56
  • 8.4 Reimbursement 57
  • 9.0 Thailand 59
  • 9.1 Opportunities 60
    • 9.1.1 Targeting physicians 60
    • 9.1.2 International trade 61
  • 9.2 Challenges61
    • 9.2.1 Patenting and licensing issues hover in the background 61
    • 9.2.2 Nurturing talent 62
    • 9.2.3 e-marketing still in its infancy 62
  • 9.3 Access issues 62
  • 9.4 Reimbursement 62
    • 9.4.1 Universal Coverage Scheme 63
    • 9.4.2 Civil Servants’ Medical Benefi t Scheme 63
    • 9.4.3 Social Security Scheme 63

10.0 Industry learning’s 66

11.0 Abbreviations67

12.0 References 68

To get more details on the report, click here to download the report extract

Top